NBC Securities Inc. Buys New Shares in U.S. Physical Therapy, Inc. (NYSE:USPH)

NBC Securities Inc. bought a new stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPHFree Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 10,784 shares of the company’s stock, valued at approximately $989,000. NBC Securities Inc. owned 0.07% of U.S. Physical Therapy as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Cambiar Investors LLC increased its stake in U.S. Physical Therapy by 10.1% during the 3rd quarter. Cambiar Investors LLC now owns 20,803 shares of the company’s stock valued at $1,908,000 after purchasing an additional 1,900 shares in the last quarter. Park Avenue Securities LLC bought a new stake in U.S. Physical Therapy during the 3rd quarter valued at $232,000. Copeland Capital Management LLC grew its stake in shares of U.S. Physical Therapy by 6.8% in the 3rd quarter. Copeland Capital Management LLC now owns 770,613 shares of the company’s stock worth $70,688,000 after acquiring an additional 49,155 shares in the last quarter. Boston Trust Walden Corp grew its stake in shares of U.S. Physical Therapy by 7.6% in the 3rd quarter. Boston Trust Walden Corp now owns 543,342 shares of the company’s stock worth $49,841,000 after acquiring an additional 38,234 shares in the last quarter. Finally, Martin Capital Advisors LLP grew its stake in shares of U.S. Physical Therapy by 4.2% in the 3rd quarter. Martin Capital Advisors LLP now owns 13,209 shares of the company’s stock worth $1,212,000 after acquiring an additional 535 shares in the last quarter.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on USPH. StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, October 18th. TheStreet lowered shares of U.S. Physical Therapy from a “b-” rating to a “c+” rating in a research note on Wednesday, October 4th. Barrington Research upped their target price on shares of U.S. Physical Therapy from $111.00 to $120.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 3rd. Finally, JPMorgan Chase & Co. reduced their target price on shares of U.S. Physical Therapy from $108.00 to $99.00 and set an “overweight” rating for the company in a research note on Friday, November 17th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $119.00.

Check Out Our Latest Analysis on USPH

U.S. Physical Therapy Price Performance

Shares of USPH stock traded down $0.27 during trading hours on Friday, reaching $94.15. The stock had a trading volume of 31,950 shares, compared to its average volume of 64,297. The stock’s fifty day simple moving average is $91.60 and its 200 day simple moving average is $96.45. The company has a current ratio of 2.77, a quick ratio of 2.77 and a debt-to-equity ratio of 0.29. U.S. Physical Therapy, Inc. has a 12 month low of $78.08 and a 12 month high of $124.11. The firm has a market capitalization of $1.41 billion, a PE ratio of 54.74, a PEG ratio of 5.62 and a beta of 1.33.

U.S. Physical Therapy (NYSE:USPHGet Free Report) last announced its earnings results on Tuesday, November 7th. The company reported $0.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.61 by $0.01. U.S. Physical Therapy had a net margin of 5.11% and a return on equity of 9.03%. The business had revenue of $150.00 million during the quarter, compared to analyst estimates of $148.85 million. During the same period in the previous year, the business posted $0.58 earnings per share. U.S. Physical Therapy’s revenue for the quarter was up 7.4% on a year-over-year basis. On average, equities research analysts predict that U.S. Physical Therapy, Inc. will post 2.53 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 8th. Shareholders of record on Thursday, November 16th were paid a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 1.83%. The ex-dividend date of this dividend was Wednesday, November 15th. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 100.00%.

Insiders Place Their Bets

In related news, Director Clayton Trier sold 1,170 shares of U.S. Physical Therapy stock in a transaction on Wednesday, December 13th. The shares were sold at an average price of $92.26, for a total value of $107,944.20. Following the transaction, the director now directly owns 7,400 shares of the company’s stock, valued at $682,724. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other U.S. Physical Therapy news, Director Clayton Trier sold 1,170 shares of the business’s stock in a transaction on Wednesday, December 13th. The shares were sold at an average price of $92.26, for a total transaction of $107,944.20. Following the transaction, the director now directly owns 7,400 shares of the company’s stock, valued at approximately $682,724. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Kathleen A. Gilmartin acquired 1,000 shares of U.S. Physical Therapy stock in a transaction on Friday, November 10th. The shares were bought at an average cost of $82.34 per share, for a total transaction of $82,340.00. Following the completion of the transaction, the director now owns 15,480 shares in the company, valued at approximately $1,274,623.20. The disclosure for this purchase can be found here. Insiders own 1.80% of the company’s stock.

U.S. Physical Therapy Company Profile

(Free Report)

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

See Also

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPHFree Report).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.